Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gailani

Showing results (131-140 of 168) with videos related to

Pageof 17
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2009
Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2)Tara C White-Adams, Michelle A Berny, Erik I Tucker, et al.
Plos One|April 6, 2016
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in MiceCharles E Bane, Ivan Ivanov, Anton Matafonov, et al.
Blood|January 31, 2022
A mechanism for hereditary angioedema caused by a lysine 311-to-glutamic acid substitution in plasminogenS Kent Dickeson, Sunil Kumar, Mao-Fu Sun, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2020
The contact activation system as a potential therapeutic target in patients with COVID-19Joseph J Shatzel, Emma P DeLoughery, Christina U Lorentz, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primatesMichael Wallisch, Christina U Lorentz, Hari H S Lakshmanan, et al.
Metabolic Brain Disease|June 21, 2023
Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in miceTia C L Kohs, Meghan E Fallon, Ethan C Oseas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Antithrombotic effect of antisense factor XI oligonucleotide treatment in primatesJeffrey R Crosby, Ulla Marzec, Alexey S Revenko, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 6, 2023
Factor XI Inhibition With Heparin Reduces Clot Formation in Simulated Pediatric Extracorporeal Membrane OxygenationAndrew D Meyer, Catherine R Thorpe, Tamara Fraker, et al.
Blood Advances|January 27, 2022
Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domainsAleksandr Shamanaev, Ivan Ivanov, Mao-Fu Sun, et al.
JRSM Cardiovascular Disease|February 29, 2020
A multifaceted investigation into molecular associations of chronic thromboembolic pulmonary hypertension pathogenesisStephen J Halliday, Daniel T Matthews, Megha H Talati, et al.
Pageof 17

Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Arteriosclerosis, Thrombosis, and Vascular Biology|August 8, 2009
Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2)Tara C White-Adams, Michelle A Berny, Erik I Tucker, et al.
Plos One|April 6, 2016
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in MiceCharles E Bane, Ivan Ivanov, Anton Matafonov, et al.
Blood|January 31, 2022
A mechanism for hereditary angioedema caused by a lysine 311-to-glutamic acid substitution in plasminogenS Kent Dickeson, Sunil Kumar, Mao-Fu Sun, et al.
Research and Practice in Thrombosis and Haemostasis|June 17, 2020
The contact activation system as a potential therapeutic target in patients with COVID-19Joseph J Shatzel, Emma P DeLoughery, Christina U Lorentz, et al.
Research and Practice in Thrombosis and Haemostasis|February 29, 2020
Antibody inhibition of contact factor XII reduces platelet deposition in a model of extracorporeal membrane oxygenator perfusion in nonhuman primatesMichael Wallisch, Christina U Lorentz, Hari H S Lakshmanan, et al.
Metabolic Brain Disease|June 21, 2023
Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in miceTia C L Kohs, Meghan E Fallon, Ethan C Oseas, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Antithrombotic effect of antisense factor XI oligonucleotide treatment in primatesJeffrey R Crosby, Ulla Marzec, Alexey S Revenko, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 6, 2023
Factor XI Inhibition With Heparin Reduces Clot Formation in Simulated Pediatric Extracorporeal Membrane OxygenationAndrew D Meyer, Catherine R Thorpe, Tamara Fraker, et al.
Blood Advances|January 27, 2022
Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domainsAleksandr Shamanaev, Ivan Ivanov, Mao-Fu Sun, et al.
JRSM Cardiovascular Disease|February 29, 2020
A multifaceted investigation into molecular associations of chronic thromboembolic pulmonary hypertension pathogenesisStephen J Halliday, Daniel T Matthews, Megha H Talati, et al.
Pageof 17